Robert T. (Bobby) Brooke, MSc

Robert T. (Bobby) Brooke, MSc is a Biotech Entrepreneur. He is a cofounder and the CEO of Vitality Biopharma, a cannabinoid drug development company that originally was formed to commercialize a stevia biosynthesis process. He currently is also cofounder and serves as CEO of Intervene Immune, a privately-held biotechnology company focused on immune system regeneration.

Bobby previously was the founder of the cancer drug development company Genesis Biopharma (now known as Iovance Biotherapeutics), where he served as Director, President, and CEO from March 2010 until February 2011.

From 2004 to 2008, he was analyst with Bristol Capital Advisors, investment manager to Bristol Investment Fund, Ltd. During this period, Bristol financed over 60 public healthcare and life science companies and was listed by The PIPEs Report in 2005 as being the most active investor in private placements by public biotechnology companies.

Bobby earned his B.Sc. in Electrical Engineering from Georgia Tech in 2003 and his M.Sc. in Biomedical Engineering from UCLA in 2005.

View his LinkedIn profile. Visit his companies Vitality Biopharma and Intervene Immune.